BRIEF published on 11/04/2024 at 11:51, 1 year 11 months ago Acticor Biotech: Publication of 2024 half-year financial results Biotechnology Finance Half-year Results Glenzocimab Judicial Recovery
PRESS RELEASE published on 11/04/2024 at 11:46, 1 year 11 months ago Inside Information / News release on accounts, results Acticor Biotech publishes its half-year financial results for 2024, highlighting repositioning of glenzocimab in STEMI treatment, receivership proceedings extension, and shareholder approvals Repositioning Shareholder Approvals ACTICOR BIOTECH Glenzocimab Half-year Financial Results
BRIEF published on 10/11/2024 at 17:50, 2 years ago Acticor Biotech Advances Glenzocimab in Myocardial Infarction Treatment Clinical Trials Myocardial Infarction ACTICOR BIOTECH Glenzocimab Cardiovascular Treatment
PRESS RELEASE published on 10/11/2024 at 17:45, 2 years ago Inside Information / Other news releases Acticor Biotech repositions glenzocimab in the treatment of myocardial infarction, evaluating efficacy and safety in phase 2 studies LIBERATE and GLORIA. Clinical trials aim to reduce infarct size and prevent complications Clinical Trials Phase 2b Myocardial Infarction ACTICOR BIOTECH Glenzocimab
BRIEF published on 07/09/2024 at 20:50, 2 years 3 months ago Acticor Biotech Reports 2023 Financial Results Financial Report Annual Results Capital Raising ACTICOR BIOTECH Glenzocimab
PRESS RELEASE published on 07/09/2024 at 20:45, 2 years 3 months ago Inside Information / News release on accounts, results Acticor Biotech publishes its 2023 annual results, financial highlights, and financing outlook. Annual General Meeting scheduled for September 13, 2024 Annual General Meeting Financial Highlights 2023 Annual Results ACTICOR BIOTECH Financing Outlook
BRIEF published on 05/15/2024 at 11:20, 2 years 5 months ago Results of the ACTISAVE study and future perspectives of ACTICOR BIOTECH Stroke Treatment ACTICOR BIOTECH Glenzocimab ESOC 2024 ACTISAVE Study
PRESS RELEASE published on 05/15/2024 at 11:15, 2 years 5 months ago Inside Information / Other news releases ACTICOR BIOTECH presents main results of phase 2/3 ACTISAVE study on stroke treatment at ESOC 2024, targeting specific subgroups for potential benefits Stroke Treatment ACTICOR BIOTECH ESOC 2024 ACTISAVE Study Patient Subgroups
Published on 11/02/2026 at 23:15, 5 hours 22 minutes ago ATHA Energy Announces Issuance of Common Shares in Satisfaction of US$25 Million Convertible Debenture Interest Payment Obligations
Published on 11/02/2026 at 22:30, 6 hours 7 minutes ago Sparton Files Morrison Mine N-I 43-101 Technical Report
Published on 11/02/2026 at 17:00, 11 hours 37 minutes ago PPX Mining Initiates Operating Permit Process for Igor Processing Plant
Published on 11/02/2026 at 17:00, 11 hours 37 minutes ago QNX Launches Global Developer Hackathon with $50,000 in Prizes to Accelerate Innovation in Mission-Critical Systems
Published on 11/02/2026 at 16:15, 12 hours 22 minutes ago ACCESS Newswire Launches SPOT, Seven AI Agents That Check Every Press Release Before Submission
Published on 11/03/2026 at 03:30, 1 hour 7 minutes ago ADTRAN Holdings, Inc. reports third quarter 2026 financial results
Published on 11/03/2026 at 03:25, 1 hour 12 minutes ago How President Xi Jinping Has Charted the Course for Boosting China's Strength in Finance: Pursuing a Path of Financial Development with Chinese Characteristics
Published on 11/03/2026 at 02:55, 1 hour 42 minutes ago WESCAN GOLDFIELDS ANNOUNCES ENGAGEMENT OF RED CLOUD SECURITIES FOR LIQUIDITY SERVICES
Published on 11/02/2026 at 23:11, 5 hours 25 minutes ago EQS-Adhoc: HUGO BOSS AG: HUGO BOSS UPDATES ITS FULL YEAR 2026 OUTLOOK
Published on 11/02/2026 at 22:05, 6 hours 32 minutes ago Abivax to Participate in Upcoming Fall Investor Conferences
Published on 11/02/2026 at 18:30, 10 hours 7 minutes ago Disclosure of transactions in own shares from October 26 to October 30, 2026
Published on 11/02/2026 at 18:17, 10 hours 20 minutes ago Reporting on share buyback transactions carried out between October 28 and October 29, 2026
Published on 11/02/2026 at 18:00, 10 hours 37 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 11/02/2026 at 17:59, 10 hours 37 minutes ago Saint-Gobain completes the divestment of its Dahl specialist distribution business in Sweden, Norway and Denmark
